Twist Bioscience Enhances Genes Product Offering with Longer Genes and Offers Access to Its Application Programming Interface

January 07, 2019 08:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced it has expanded its product portfolio to offer genes up to five kilobases (5kb) in length at industry-leading pricing. In addition, Twist is making its... Read more

Paragon Genomics Partners with MGI Tech to Distribute its CleanPlex® NGS Target Enrichment Panels Worldwide

–Subsidiary of BGI Group Will Distribute CleanPlex® NGS Target Enrichment Panels Optimized for Its MGISEQ and BGISEQ Sequencing Platforms in All Territories Outside the U.S.– –Paragon Genomics Will Distribute MGI’s Automated Sample Preparation Systems in the U.S. and Canada with Optimized CleanPlex Chemistries Providing a Complete Automated Solution– HAYWARD, CA – January 6, 2019 –... Read more

Barben Analytical Launches OXYvisor™ Next-Generation Process Oxygen Analyzer

Friday, January 4, 2019 JOIN THE CONVERSATION CARSON CITY, NV – Barben Analytical, a leader in pH/ORP, oxygen and conductivity measurement products, has introduced OXYvisor, its second-generation process oxygen analyzer, which optically measures oxygen in either the gas or liquid phase. In terms of performance, OXYvisor has no equal in the marketplace for trace level... Read more

Christine Tsingos Announces Plans to Retire as CFO of Bio-Rad Laboratories, Inc. Effective April 30, 2019

Date: 01/03/2019 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Christine A. Tsingos has informed the company of her intention to retire as Executive Vice President and Chief Financial Officer effective April 30, 2019. Ms. Tsingos will remain in her current... Read more

The Board of Biotage AB initiates recruitment of a new CEO

WED, JAN 02, 2019 08:45 CET The Board of Biotage AB (Biotage), (Nasdaq Stockholm: BIOT.ST) today announces that a recruitment process has been initiated to hire a new CEO. The current CEO’s employment contract expires in April 2020. Torben Jørgensen has declared that he intends to continue as Biotage’s CEO up and until a replacement... Read more

Promega Microsatellite Instability Technology Receives Innovation Designation from Chinese National Medical Products Administration

Madison, WI USA. (January 2, 2019) Promega Corporation’s latest microsatellite instability (MSI) technology has been granted innovation designation by the Chinese National Medical Products Administration (NMPA). Promega MSI technology has been validated in labs around the world. With innovation status, the path to become classified as an invitro diagnostic (IVD) will gain elevated efficiency by having... Read more

BioTek Announces New Epoch™ 2 Microplate Spectrophotometer

January 2, 2019 BioTek Instruments introduces their next generation Epoch™ 2 Microplate Spectrophotometer; with added features that enable multiple conveniences for performing absorbance measurements. Epoch 2 now includes monochromator-based individual wavelength selection or wavelength scanning from 200-999 nm to accommodate an extensive range of assays, including nucleic acid and protein quantification, ELISA, microbial growth, endotoxin, ROS assays... Read more

Anton Paar opens subsidiaries in Spain and Taiwan

2018-12-21 To strengthen activities in Spain and Taiwan and provide the best and immediate support via Anton Paar specialists, Anton Paar GmbH established a new subsidiary in Spain: Anton Paar Spain S.L.U with offices in Madrid and Barcelona. Following the cooperation with a distribution partner that started in 1996, from January 1, 2019, Anton Paar... Read more

Massachusetts Governor Charlie Baker tours new 908 Devices Boston Headquarters

12.20.18 908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, were honored today to host Massachusetts Governor Charlie Baker for a tour of their new corporate headquarters. Fueled by expanding R&D and increased manufacturing needs, 908 Devices relocated to the Pappas Commerce Center at the heart of Boston’s Seaport District in... Read more